| Nov 8 |
What Makes Century Therapeutics (IPSC) a New Buy Stock
|
| Nov 6 |
Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 5 |
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 5 |
Century Therapeutics Non-GAAP EPS of -$0.37 beats by $0.08, revenue of $0.8M beats by $0.25M
|
| Nov 5 |
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
|
| Nov 5 |
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
|
| Nov 4 |
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
|
| Oct 28 |
We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate
|
| Oct 22 |
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?
|
| Sep 26 |
Century Therapeutics taps Morgan Conn as CFO
|
